Status:
UNKNOWN
The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Cervical Cancer
Cervical Intraepithelial Neoplasia
Eligibility:
FEMALE
18-80 years
Phase:
NA
Brief Summary
A. To investigate the relationship between serum titer of anti-HPV16 antibody and clinicopathological factors of cervical cancer patients. B. To investigate that if the serum titer of anti-HPV16 anti...
Detailed Description
Cervical cancer is the most frequent neoplasm of the women in Taiwan and in the world. Cervical cancer affects half a million women each year and results in about 200,000 worldwide and it also influen...
Eligibility Criteria
Inclusion
- cervical intrapeithelial neoplasm
- Cervical cancer
Exclusion
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2011
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT00728871
Start Date
December 1 2005
End Date
December 1 2011
Last Update
August 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Natioanal Taiwan Univ. Hospital
Taipei, Taiwan, China, 100